ClinicalTrials.Veeva

Menu

Impact of Tramadol and Oxycodone on Sleep Apnea (TROXAT)

V

Vaud University Hospital Center

Status and phase

Completed
Phase 4

Conditions

Sleep Apnea

Treatments

Drug: Oxycodone
Drug: Tramadol

Study type

Interventional

Funder types

Other

Identifiers

NCT03454217
CER 2017-01976

Details and patient eligibility

About

Postoperative pain is usually treated with opioids. Among them, oxycodone is popular in the daily practice as it is administered orally and is easily titrated. However, side-effects include increase duration and frequency of apneic episodes. Some authors believe that tramadol has less impact on these apneic episodes during the first postoperative night, based on a trial that reported conclusive results only during the first 2 postoperative hours. The objective of this randomized controlled trial is to compare the effect of postoperative pain treatment of oxycodone with tramadol on apneic episodes during the first and third postoperative nights.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients scheduled for orthopaedic surgery on the lower limb under a spinal anaesthesia
  • physical status I-III

Exclusion criteria

  • planned surgical duration more than 3 hours
  • contraindication to spinal anaesthesia
  • severe respiratory disease
  • patient treated for sleep apnea syndrome
  • allergy to tramadol or oxycodone

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups

Oxycodone
Active Comparator group
Description:
Postoperative pain treatment with oxycodone
Treatment:
Drug: Oxycodone
Tramadol
Active Comparator group
Description:
Postoperative pain treatment with tramadol
Treatment:
Drug: Tramadol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems